310 related articles for article (PubMed ID: 27624963)
21. Synthesis and immunochemical characterization of S-linked glycoconjugate vaccines against Candida albicans.
Wu X; Lipinski T; Paszkiewicz E; Bundle DR
Chemistry; 2008; 14(21):6474-82. PubMed ID: 18543264
[TBL] [Abstract][Full Text] [Related]
22. Designing a new antifungal glycoconjugate vaccine.
Johnson MA; Bundle DR
Chem Soc Rev; 2013 May; 42(10):4327-44. PubMed ID: 23232662
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and immunological studies of β-1,2-mannan-peptide conjugates as antifungal vaccines.
Liao J; Pan B; Liao G; Zhao Q; Gao Y; Chai X; Zhuo X; Wu Q; Jiao B; Pan W; Guo Z
Eur J Med Chem; 2019 Jul; 173():250-260. PubMed ID: 31009911
[TBL] [Abstract][Full Text] [Related]
25. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
26. [The quantitative assay of (1-->3)-beta-D-glucan in culture medium of Candida albicans using G-test].
Kato H; Nakao A; Kambe T; Tanaka K; Tamura H; Tanaka S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):329-33. PubMed ID: 8321180
[TBL] [Abstract][Full Text] [Related]
27. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
28. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology.
Wu X; Bundle DR
J Org Chem; 2005 Sep; 70(18):7381-8. PubMed ID: 16122263
[TBL] [Abstract][Full Text] [Related]
30. Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1,6-long glycoside side-chain-branched beta-glucan.
Sato T; Iwabuchi K; Nagaoka I; Adachi Y; Ohno N; Tamura H; Seyama K; Fukuchi Y; Nakayama H; Yoshizaki F; Takamori K; Ogawa H
J Leukoc Biol; 2006 Jul; 80(1):204-11. PubMed ID: 16670126
[TBL] [Abstract][Full Text] [Related]
31. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
Xin H; Glee P; Adams A; Mohiuddin F; Eberle K
Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005
[TBL] [Abstract][Full Text] [Related]
32. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
[TBL] [Abstract][Full Text] [Related]
33. Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients.
Torosantucci A; Tumbarello M; Bromuro C; Chiani P; Posteraro B; Sanguinetti M; Cauda R; Cassone A
Sci Rep; 2017 Jun; 7(1):2722. PubMed ID: 28578431
[TBL] [Abstract][Full Text] [Related]
34. Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence.
Yang M; Solis NV; Marshall M; Garleb R; Zhou T; Wang D; Swidergall M; Pearlman E; Filler SG; Liu H
PLoS Pathog; 2022 Jan; 18(1):e1010192. PubMed ID: 34995333
[TBL] [Abstract][Full Text] [Related]
35. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
36. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
37. Potential of anti-Candida antibodies in immunoprophylaxis.
Cabezas J; Albaina O; Montañez D; Sevilla MJ; Moragues MD; Pontón J
Immunotherapy; 2010 Mar; 2(2):171-83. PubMed ID: 20635926
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil Attack Triggers Extracellular Trap-Dependent Candida Cell Wall Remodeling and Altered Immune Recognition.
Hopke A; Nicke N; Hidu EE; Degani G; Popolo L; Wheeler RT
PLoS Pathog; 2016 May; 12(5):e1005644. PubMed ID: 27223610
[TBL] [Abstract][Full Text] [Related]
39. Whole glucan particles as a vaccine against murine aspergillosis.
Clemons KV; Danielson ME; Michel KS; Liu M; Ottoson NC; Leonardo SM; Martinez M; Chen V; Antonysamy MA; Stevens DA
J Med Microbiol; 2014 Dec; 63(Pt 12):1750-1759. PubMed ID: 25288643
[TBL] [Abstract][Full Text] [Related]
40. Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.
Magliani W; Conti S; Giovati L; Maffei DL; Polonelli L
Front Biosci; 2008 May; 13():6920-37. PubMed ID: 18508705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
